We are live on ! Find out more
Assenagon Asset Management

Assenagon Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 50.57%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
AUM
$28.9B
AUM Growth
+$733M
Cap. Flow
-$1.44B
Cap. Flow %
-4.98%
Top 10 Hldgs %
34.77%
Holding
1,514
New
116
Increased
529
Reduced
586
Closed
199

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$431M
2
META icon
Meta Platforms (Facebook)
META
+$334M
3
AAPL icon
Apple
AAPL
+$285M
4
NKE icon
Nike
NKE
+$162M
5
SU icon
Suncor Energy
SU
+$157M

Sector Composition

Rank Sector Weight
1 Technology 21.1%
2 Consumer Discretionary 16.49%
3 Healthcare 13.05%
4 Communication Services 10.82%
5 Financials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLSD
1301
DELISTED
Clearside Biomedical
CLSD
$80.4K ﹤0.01%
4,785
-5,324
-53% -$91.7K
ACET icon
1302
Adicet Bio
ACET
$74.7M
$80.1K ﹤0.01%
2,060
NXTC icon
1303
NextCure
NXTC
$26.7M
$79.1K ﹤0.01%
+3,660
New +$72.1K
MCHB
1304
Mechanics Bancorp
MCHB
$3.68B
$69.8K ﹤0.01%
11,792
-75,251
-86% -$707K
TARA icon
1305
Protara Therapeutics
TARA
$232M
$69.4K ﹤0.01%
29,051
+11,715
+68% +$34.8K
CAMP
1306
DELISTED
CalAmp Corp.
CAMP
$61.2K ﹤0.01%
+2,508
New +$122K
FARM
1307
DELISTED
Farmer Brothers
FARM
$49.5K ﹤0.01%
17,854
TIL icon
1308
Instil Bio
TIL
$50.3M
$49.3K ﹤0.01%
4,470
-2,494
-36% -$30.5K
QTTB icon
1309
Q32 Bio
QTTB
$464M
$43.8K ﹤0.01%
2,751
+1,766
+179% +$31.7K
SYRS
1310
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$32.7K ﹤0.01%
10,376
ARAV
1311
DELISTED
Aravive, Inc. Common Stock
ARAV
$25.6K ﹤0.01%
20,340
-180,113
-90% -$292K
FLNT
1312
Fluent
FLNT
$120M
$23.4K ﹤0.01%
6,219
-1,497
-19% -$6.3K
EIGR
1313
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$13.8K ﹤0.01%
+653
New +$20.1K
BFX
1314
DELISTED
BowFlex Inc.
BFX
$12.7K ﹤0.01%
10,446
-3,712
-26% -$4.72K
VRAY
1315
DELISTED
ViewRay, Inc.
VRAY
$5.59K ﹤0.01%
15,859
-364,580
-96% -$378K
AA icon
1316
Alcoa
AA
$13.2B
-24,605
Closed -$1.05M
AAP icon
1317
Advance Auto Parts
AAP
$3.49B
-202,198
Closed -$24.6M
ADBE icon
1318
CALL
Adobe
ADBE
$105B
-2,900
Closed -$1.12M
ADVM
1319
DELISTED
Adverum Biotechnologies
ADVM
-84,065
Closed -$603K
AEIS icon
1320
Advanced Energy
AEIS
$13B
-11,234
Closed -$1.1M
AKBA icon
1321
Akebia Therapeutics
AKBA
$252M
-12,450
Closed -$6.98K
AL
1322
DELISTED
Air Lease Corp
AL
-134,563
Closed -$5.3M
ALDX icon
1323
Aldeyra Therapeutics
ALDX
$93.5M
-645,020
Closed -$6.41M
AMKR icon
1324
Amkor Technology
AMKR
$13.7B
-90,734
Closed -$2.36M
AMN icon
1325
AMN Healthcare
AMN
$1.4B
-35,637
Closed -$2.96M

Similar funds

Assenagon Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Assenagon Asset Management held 1,514 positions worth $28.9B, up 2.6% from $28.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Assenagon Asset Management withdrew a net $1.44B in Q2 2023, closing 199 positions and reducing 586 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $127M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Assenagon Asset Management opened a new position in NRG Energy worth $109M.

  • Assenagon Asset Management's largest Q2 2023 buy was NRG Energy: 2,913,877 shares worth $109M.
  • Assenagon Asset Management added most to Amazon in Q2 2023, an estimated $431M increase.
  • Assenagon Asset Management's biggest Q2 2023 reduction was Alphabet (Google) Class A, cutting an estimated $359M.
  • Assenagon Asset Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $127M.
  • Assenagon Asset Management's ten largest holdings make up 35% of its $28.9B portfolio in Q2 2023.
  • Assenagon Asset Management opened 116 new positions and closed 199 in Q2 2023.
  • Assenagon Asset Management's portfolio value rose 2.6% quarter-over-quarter to $28.9B.

Based on Assenagon Asset Management's 13F filing for Q2 2023, filed 25 Jul 2023.